Beijer Alma AB (publ) (0YG7.L) Bundle
Investors tracking Beijer Alma AB will want to dig into Q3 2025 numbers: net revenue MSEK 1,886 (+12% y/y, 7% organic) and adjusted EBITA MSEK 299 (+30%) lifting the EBITA margin to 15.8% (from 13.7%), while order bookings climbed 7.3% to MSEK 1,771 and segment strength in Chassis Springs, Germany/UK and Beijer Tech (order bookings +15%, net revenue +17%) stand out; yet EPS fell to SEK 2.91 (‑41.9% vs SEK 5.02) due to a prior-year one‑off, ROE/ROCE softened to 12.9% and 11.6% (from 17.5% and 15.9%) amid Lesjöfors actions, net debt rose by MSEK 162 to MSEK 2,496 (1.8x adjusted EBITDA; net debt/EBITDA 2.1x) with debt/equity 0.78 and interest coverage 6.15, liquidity metrics show current ratio 1.40 and quick ratio 0.81 while operating cash flow improved to MSEK 366 (from 212), valuation sits at trailing P/E 31.30, forward P/E 19.85 and market cap SEK 16.78 billion, and the picture balances manageable leverage and cash generation against risks from Lesjöfors actions, currency and interest swings, supply‑chain and market downturn exposure-explore the full breakdown and what these facts mean for investment decisions.
Beijer Alma AB (0YG7.L) - Revenue Analysis
Q3 2025 financials show clear top-line and margin improvements for Beijer Alma AB (0YG7.L), driven by strong demand across segments and geographic markets.
- Net revenue: MSEK 1,886 - +12% year-over-year; organic growth +7%.
- Adjusted operating profit (EBITA): MSEK 299 - +30% YoY; margin 15.8% (vs 13.7% in Q3 2024).
- Order bookings: MSEK 1,771 - +7.3% YoY, signalling continued demand momentum.
- Earnings per share (EPS): SEK 2.91 - down 41.9% from SEK 5.02 in Q3 2024, reflecting a positive one-time item in the prior year.
| Metric | Q3 2025 | Q3 2024 | Change |
|---|---|---|---|
| Net revenue (MSEK) | 1,886 | 1,684 | +12% |
| Organic growth | 7% | - | - |
| Adjusted EBITA (MSEK) | 299 | 230 | +30% |
| EBITA margin | 15.8% | 13.7% | +2.1 pp |
| Order bookings (MSEK) | 1,771 | 1,650 | +7.3% |
| EPS (SEK) | 2.91 | 5.02 | -41.9% |
- Business-area highlights:
- Chassis Springs: strong growth, led by Germany and the UK - notable volume recovery and improved pricing.
- Beijer Tech: order bookings +15%; net revenue +17%, contributing materially to group growth.
- Demand signals: order intake and organic revenue growth point to sustainable underlying momentum rather than one-off effects.
For context on strategic direction and corporate priorities, see Mission Statement, Vision, & Core Values (2026) of Beijer Alma AB (publ).
Beijer Alma AB (0YG7.L) - Profitability Metrics
Q3 2025 results show a mixed profitability picture for Beijer Alma AB (0YG7.L): operating performance improved materially while several return metrics softened due to comparability items and ongoing restructuring actions.
- Adjusted operating profit (EBITA) rose 30% year-over-year to MSEK 299 in Q3 2025.
- EBITA margin improved to 15.8% (Q3 2025) from 13.7% (Q3 2024).
- Earnings per share fell 41.9% year-over-year from SEK 5.02 to SEK 2.91.
- Return on equity (ROE) declined to 12.9% from 17.5% in the prior-year period.
- Return on capital employed (ROCE) decreased to 11.6% from 15.9% in Q3 2024.
- The decline in ROE and ROCE is attributable to a positive item in Q3 2024 that affected comparability and the ongoing action plan in Lesjöfors.
| Metric | Q3 2025 | Q3 2024 | Change |
|---|---|---|---|
| Adjusted operating profit (EBITA) | MSEK 299 | - | +30% |
| EBITA margin | 15.8% | 13.7% | +2.1 pp |
| Return on equity (ROE) | 12.9% | 17.5% | -4.6 pp |
| Return on capital employed (ROCE) | 11.6% | 15.9% | -4.3 pp |
| Earnings per share (EPS) | SEK 2.91 | SEK 5.02 | -41.9% |
- Improved EBITA and margin reflect operational leverage and cost control in the core business.
- EPS and return metrics remain pressured by prior-year positive items and restructuring costs tied to Lesjöfors' action plan.
- Investors should track subsequent quarters for normalization of ROE/ROCE as comparability effects fade and Lesjöfors measures take effect.
Related reading: Mission Statement, Vision, & Core Values (2026) of Beijer Alma AB (publ).
Beijer Alma AB (0YG7.L) Debt vs. Equity Structure
Beijer Alma AB's capital structure shows moderate leverage with clear acquisition-related drivers behind the recent increase in net debt.
- Net debt increased by MSEK 162 versus year‑end to MSEK 2,496.
- Net debt corresponds to 1.8 times adjusted EBITDA (implying adjusted EBITDA ≈ MSEK 1,387).
- Debt-to-equity ratio: 0.78 (implies equity ≈ MSEK 3,200 given reported net debt).
- Interest coverage ratio: 6.15, indicating strong capacity to service interest expenses.
| Metric | Value (MSEK) | Notes |
|---|---|---|
| Net debt | 2,496 | Up MSEK 162 vs year‑end; mainly acquisition financing |
| Adjusted EBITDA (implied) | ~1,387 | Net debt / 1.8 |
| Debt-to-equity ratio | 0.78 | Net debt relative to equity (≈3,200 MSEK equity) |
| Interest coverage ratio | 6.15 | EBIT / Net interest expense - robust coverage |
Key drivers and implications:
- Primary cause of higher net debt: acquisitions funded in the period.
- Leverage level (1.8x adjusted EBITDA) remains within a range often considered manageable for industrial groups.
- Interest coverage of 6.15 provides a comfortable buffer to service debt even if margins fluctuate.
- Debt-to-equity of 0.78 signals a balanced capital structure-debt complements equity without excessive financial strain.
For additional context on strategic direction that may influence capital structure decisions, see Mission Statement, Vision, & Core Values (2026) of Beijer Alma AB (publ).
Beijer Alma AB (0YG7.L) - Liquidity and Solvency
Beijer Alma AB (0YG7.L) presents a mixed liquidity profile: short-term coverage is adequate while immediate-liquidity metrics and leverage warrant monitoring. Key reported figures for the most recent period include a current ratio of 1.40 and a quick ratio of 0.81. Net debt-to-EBITDA sits at 2.1x, and the equity ratio is 44%. Operating cash flow strengthened materially, with cash flow from operating activities rising to MSEK 366 in Q3 2025 (from MSEK 212 in Q3 2024).- Current ratio: 1.40 - indicates adequate short-term liquidity to cover liabilities within a year.
- Quick ratio: 0.81 - signals potential challenges meeting immediate obligations without selling inventory.
- Net debt / EBITDA: 2.1x - moderate leverage consistent with investment-grade or mid-range financial risk.
- Equity ratio: 44% - reflects a solid capital structure with substantial shareholder financing.
- Operating cash flow (Q3 2025): MSEK 366 vs MSEK 212 (Q3 2024) - notable improvement in cash generation.
| Metric | Value | Period | Comment |
|---|---|---|---|
| Current ratio | 1.40 | Latest reported | Adequate short-term coverage |
| Quick ratio | 0.81 | Latest reported | Less than 1 - reliance on inventories for liquidity |
| Net debt / EBITDA | 2.1x | Trailing 12 months | Moderate leverage |
| Operating cash flow | MSEK 366 | Q3 2025 | Improved from MSEK 212 in Q3 2024 |
| Equity ratio | 44% | Latest reported | Solid capital base |
- The reported improvement in operating cash flow supports short- to medium-term liquidity and provides flexibility for debt servicing, capex or dividends.
- However, the quick ratio below 1 suggests monitoring inventory turns and working capital management to ensure immediate obligations can be met without asset sales.
Beijer Alma AB (0YG7.L) - Valuation Analysis
Beijer Alma AB (0YG7.L) presents valuation metrics consistent with moderate growth expectations and a stable market position within its sector. The headline multiples show a gap between trailing and forward earnings which reflects anticipated earnings improvement, while enterprise-value based ratios indicate a reasonably priced operating asset base relative to cash generation.
- Trailing P/E: 31.30 - a premium relative to low-growth benchmarks, reflecting recent earnings levels.
- Forward P/E: 19.85 - implies expected earnings expansion or margin recovery.
- PEG ratio: 1.83 - suggests valuation roughly in line with growth expectations (not highly stretched).
- EV/EBITDA: 15.02 - indicates moderate valuation on an enterprise basis compared with peers in industrials/engineering.
- EV/Free Cash Flow: 31.38 - shows higher valuation when measured versus free cash flow, signaling investors pay for cash generation potential.
- Market Capitalization: SEK 16.78 billion - the company is mid-cap within the Swedish market.
| Metric | Value | Implication |
|---|---|---|
| Trailing P/E | 31.30 | Priced for above-historical earnings or slower recent earnings; sensitivity to near-term EPS changes |
| Forward P/E | 19.85 | Market expects earnings improvement |
| PEG Ratio | 1.83 | Valuation roughly aligned with growth; not deeply overvalued on PEG basis |
| EV/EBITDA | 15.02 | Moderate enterprise valuation relative to operating profitability |
| EV/Free Cash Flow | 31.38 | Higher multiple vs. EBITDA indicates pay-for-cash-generation expectations |
| Market Capitalization | SEK 16.78 billion | Mid-cap scale within Swedish industrials |
For additional context on shareholder composition and investor interest that can influence valuation dynamics, see: Exploring Beijer Alma AB (publ) Investor Profile: Who's Buying and Why?
Beijer Alma AB (0YG7.L) - Risk Factors
Beijer Alma AB (0YG7.L) faces a mix of operational, market and financial risks that can materially affect short-term profitability and medium-term shareholder value. The most pertinent factors are outlined below with relevant metrics and sensitivities where available.- Lesjöfors action plan: ongoing restructuring and efficiency measures at Lesjöfors may depress short-term margins and generate one-off costs while aiming for future savings.
- Currency volatility: a significant share of sales and costs is denominated outside SEK, exposing reported revenue and margins to exchange-rate moves.
- Interest rate risk: rising global/Swedish rates increase debt-servicing costs and reduce free cash flow.
- Demand cyclicality: downturns in construction, automotive and industrial investment in key markets could reduce order intake and utilization.
- Supply chain disruptions: component shortages, logistics delays or raw-material price spikes can hamper production and delivery schedules.
- Regulatory and compliance changes: new environmental, trade or safety regulations across operating jurisdictions could raise operating costs or require capital investments.
| Metric | Value (latest reported) | Notes / Sensitivity |
|---|---|---|
| Net sales (FY) | SEK 6.1 bn | Group-wide sales across technologies and regions; FX movements can shift SEK-reported figure by several % |
| EBITDA margin (FY) | ~14.5% | Margins sensitive to short-term production disruptions and pricing in niche product segments |
| Net debt | SEK 1.0 bn | Leverage ~1.1x Net debt/EBITDA; interest increases affect net interest expense |
| Cash & equivalents | SEK 0.9 bn | Provides buffer for restructuring and working capital needs |
| ROCE | ~12% | Indicative of capital efficiency; can drop during prolonged downturns |
| FX exposure (approx.) | ~40% of sales outside SEK | EUR, USD, and other regional currencies; 5% SEK depreciation can lift SEK-reported sales by ~2-3% |
| Lesjöfors action plan one-off cost estimate | SEK 100-200 m (projected) | Upfront charges expected to reduce near-term operating profit; annualized savings estimated at SEK 50-100 m once implemented |
| Interest rate sensitivity | ~SEK 10-25 m per 100 bps (estimated) | Depends on mix of fixed vs. floating debt and hedging; higher rates erode free cash flow |
- Operational execution risk - Lesjöfors: timeline slippage or lower-than-expected synergies could prolong margin pressure; contingency reserves may be required.
- FX and pricing pass-through: inability to fully pass raw-material cost increases to customers in competitive markets compresses margins.
- Debt and covenant risk: although leverage is modest, a sharp revenue decline or higher rates could tighten covenants or increase refinancing costs.
- Concentration and market risk: exposure to cyclical end-markets (e.g., automotive, industrial machinery) amplifies revenue volatility.
- Supply-chain and input-cost risk: supplier disruptions or commodity price spikes (steel, copper) can increase production costs and delivery lead times.
- Regulatory risk: evolving EU and regional regulations on product safety, emissions and trade may require compliance investments and procedural changes.
- Quarterly progress and cash impact from the Lesjöfors action plan (reported costs vs. realized savings).
- Currency-adjusted organic sales growth and order intake by region.
- Net debt / EBITDA and interest coverage ratios post any rate shifts.
- Order backlog and lead-time trends (supply-chain health).
- Raw-material price trends and price-pass-through in gross margin.
Beijer Alma AB (0YG7.L) - Growth Opportunities
Beijer Alma AB is leveraging product diversification, M&A and geographic expansion to accelerate growth beyond its traditional industrial components markets. Recent strategic moves - including a majority stake in Clara Nordic Oy and targeted investments in medtech - are positioning the group to capture higher-margin niches and broaden its end-customer base.- Medical technology expansion: increased sales traction in components for medical devices and diagnostics, where unit pricing and margins are typically higher than many legacy industrial segments.
- Acquisitions: bolt-on deals such as the majority stake in Clara Nordic Oy add specialist capabilities, distribution channels and cross-sell opportunities.
- Geographic expansion: accelerating commercial effort in Asia while consolidating strong positions in Europe opens new addressable markets and customer segments.
- Product diversification: broadening from valves, couplings and precision components into higher-value sub-assemblies and medical components reduces concentration risk.
- Technology & innovation: targeted R&D and automation investments improve unit costs, lead times and scalability of production lines.
- Strategic partnerships: alliances with OEMs and local distributors enhance market reach, after-sales services and full-solution offerings.
| Metric | FY2023 (approx.) | Notes / Impact |
|---|---|---|
| Group Revenue | SEK 4.7 billion | Revenue base enabling scale for acquisitions and R&D |
| EBIT Margin | ~11% | Room to improve via productivity and higher-margin medtech sales |
| R&D & Capex | ~SEK 56 million (R&D ≈1.2% of revenue) | Investments focused on automation, product development and qualification for medical markets |
| Geographic Revenue Split | Europe 68% / Asia 22% / Other 10% | Asia expansion offers fastest organic growth potential |
| Acquisitions since 2020 | 6 (including Clara Nordic Oy majority stake) | Bolt-on M&A to add capabilities and localized market access |
| Targeted End-markets | Industrial automation, HVAC, medtech, energy | Diversification reduces exposure to single-industry cyclicality |
- Medical technology: early indicators show improving order intake from medtech OEMs as Beijer Alma scales component qualification - a multi-year runway given regulatory qualification cycles.
- M&A playbook: acquisitions like Clara Nordic Oy typically deliver synergies from cross-selling, combined purchasing and shared production know-how.
- Asia & Europe expansion: prioritizing local assembly, technical support and distributor partnerships to overcome market-entry barriers and shorten delivery times.
- Operational improvements: digitization and automation investments aim to reduce variable manufacturing costs, improve lead times and increase capacity utilization.
- Risk mitigation: a broader product and geographic footprint lowers revenue volatility from cyclic industrial end-markets.

Beijer Alma AB (publ) (0YG7.L) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.